middle.news
AdAlta Launches $1.3M Rights Issue to Fuel Cellular Immunotherapy Push
3:36am on Monday 2nd of June, 2025 AEST
•
Biotechnology
Read Story
AdAlta Launches $1.3M Rights Issue to Fuel Cellular Immunotherapy Push
3:36am on Monday 2nd of June, 2025 AEST
Key Points
2-for-3 renounceable rights issue priced at 0.3 cents per share
Free attaching options exercisable at 1 cent with three-year term
Partially underwritten to $0.3 million by Mahe Capital
Funds to advance CAR-T in-licensing and evaluate strategic assets
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Adalta (ASX:1AD)
OPEN ARTICLE